NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Pharmacotherapy in Obesity: Not Just for Three Months
Overweight and obesity rates continue to climb worldwide, contributing to significant morbidity and mortality, despite several effective pharmacotherapy treatments that are grossly underutilized. Obesity is…
When Is It Reasonable to Consider Withholding Lipid Lowering Therapy?
Lipid lowering therapy is a cornerstone of cardiovascular risk reduction. However, withholding or stopping lipid lowering therapy may be worth consideration in some individuals. These…
Improving Lipid Management for the Acute Coronary Syndrome Patient
Introduction It’s been over 20 years since the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial1 ushered in the initiation of aggressive LDL-C lowering…
How We Do It: Lipid Specialists Pushing Boundaries to Improve Patient Care Across a Variety of Practice Settings
The NLA now includes > 2,000 members with representation from physicians, NP/PAs, clinical pharmacists, dietitians, and other healthcare professionals. In this Clinical Feature, we highlight…
The Lipid Panel – Chylomicronemia
The Lipid Panel – Imaging: Is My Treatment Working?
S3E2: Statin Underuse Persistence
Alan S. Brown, MD, FACC, MNLA talks with Mary Katherine Cheeley, PharmD, CLS, FNLA about the persistence of statin underuse in practice.
